$35.03
+3.5%CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Last Annual Value
355.54M
3-Year CAGR
2%
5-Year CAGR
13%
10-Year CAGR
8%
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() CONMED Corporation NYSE:CNMD | 355.54M | 3.8% | 8.9% | 10.1% | |
![]() AdaptHealth Corp. NASDAQ:AHCO | 151.25M | 10.0% | 4.2% | N/A | |
![]() Neogen Corporation NASDAQ:NEOG | 190.86M | 12.6% | 13.6% | 11.5% | |
![]() Kestra Medical Technologies, Ltd. NASDAQ:KMTS | 6.57M | 46.0% | N/A | N/A | |
![]() UFP Technologies, Inc. NASDAQ:UFPT | 86.86M | 7.4% | 21.0% | 19.9% | |
![]() NovoCure Limited NASDAQ:NVCR | 0.00 | N/A | N/A | N/A | |
![]() Intellia Therapeutics, Inc. NASDAQ:NTLA | 0.00 | N/A | N/A | N/A | |
![]() SS Innovations International, Inc. NASDAQ:SSII | 17.06M | 39.2% | N/A | N/A | |
![]() Azenta, Inc. NASDAQ:AZTA | 74.96M | -16.4% | 4.4% | -2.1% |
Continue your CNMD research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.